The in vitro synergistic and antibiofilm activity of Ceftazidime/avibactam against Achromobacter species recovered from respiratory samples of cystic fibrosis patients

被引：0
|
作者：
Emel Mataracı-Kara [1 ]
Damla Damar-Çelik [1 ]
Berna Özbek-Çelik [2 ]
机构：
[1] Istanbul University,Department of Pharmaceutical Microbiology, Faculty of Pharmacy
[2] Marmara University,Department of Pharmaceutical Microbiology, Faculty of Pharmacy
来源：
European Journal of Clinical Microbiology & Infectious Diseases | 2025年 / 44卷 / 3期
关键词：
Ceftazidime/avibactam; Synergy; spp.; Bactericidal activity; Antibiofilm activity;
D O I：
10.1007/s10096-024-05017-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：587 / 596
页数：9
相关论文
共 50 条
  • [31] Antibiofilm Activity of Different Washing Solutions against Biofilms in Cystic Fibrosis Patients' Nasal Cavities
    Tuzemen, Goekhan
    Tuzemen, Nazmiye Ulku
    Alkan, Perihan Erkan
    Ozakin, Cueneyt
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2023, 18 (05) : 250 - 255
  • [32] In vitro activity of cefiderocol against comparators (ceftazidime-avibactam, ceftazidime-avibactam/aztreonam combination, and colistin) against clinical isolates of meropenem-resistant Klebsiella pneumoniae from India
    Borde, Kalyani
    Kareem, M. A.
    Sharma, Ratna Mani
    Dass, S. Manick
    Ravi, Vedantham
    Mathai, Dilip
    Powell, Eleanor A.
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [33] Molecular epidemiology of Aspergillus species and other moulds in respiratory samples from Argentinean patients with cystic fibrosis
    Devoto, Tomas Brito
    Hermida Alava, Katherine Stefania
    Pola, Santiago J.
    Pereda, Rosana
    Rubeglio, Etelvina
    Finquelievich, Jorge L.
    Cuestas, Maria L.
    MEDICAL MYCOLOGY, 2020, 58 (07) : 867 - 873
  • [34] Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes
    Nielsen, Signe M.
    Norskoy-Lauritsen, Niels
    Bjarnsholt, Thomas
    Meyer, Rikke L.
    MICROORGANISMS, 2016, 4 (03)
  • [35] Evaluation of in vitro activity of ceftazidime/avibactam and ceftolozane/tazobactam against MDR Pseudomonas aeruginosa isolates from Qatar
    Ahmed, Mazen A. Sid
    Hadi, Hamad Abdel
    Hassan, Abubaker A., I
    Abu Jarir, Sulieman
    Al-Maslamani, Muna A.
    Eltai, Nahla Omer
    Dousa, Khalid M.
    Hujer, Andrea M.
    Sultan, Ali A.
    Soderquist, Bo
    Bonomo, Robert A.
    Ibrahim, Emad Bashir
    Jass, Jana
    Omrani, Ali S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (12) : 3497 - 3504
  • [36] Multilocus Sequence Analysis of Isolates of Achromobacter from Patients with Cystic Fibrosis Reveals Infecting Species Other than Achromobacter xylosoxidans
    Ridderberg, Winnie
    Wang, Mikala
    Norskov-Lauritsen, Niels
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (08) : 2688 - 2694
  • [37] In vitro activity of F901318 against filamentous fungi from cystic fibrosis patients
    Seufert, R.
    Dittmer, S.
    Heep, M.
    Rath, P. M.
    Steinmann, J.
    MYCOSES, 2018, 61 : 14 - 15
  • [38] In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis
    Ruiz, Victor H.
    Fratoni, Andrew
    Nicolau, David P.
    Kuti, Joseph L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023,
  • [39] In vitro activity of F901318 against filamentous fungi from cystic fibrosis patients
    Steinmann, J.
    Dittmer, S.
    Heep, M.
    Rath, P-M.
    MEDICAL MYCOLOGY, 2018, 56 : S83 - S83
  • [40] Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis
    Damar-Celik, Damla
    Norskov-Lauritsen, Niels
    Ozbek-Celik, Berna
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 713 - 717
12345